American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer

GH Lyman, M Carrier, C Ay, M Di Nisio… - Blood …, 2021 - ashpublications.org
Background: Venous thromboembolism (VTE) is a common complication among patients
with cancer. Patients with cancer and VTE are at a markedly increased risk for morbidity and …

American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism

TL Ortel, I Neumann, W Ageno, R Beyth… - Blood …, 2020 - ashpublications.org
In August 2022, these guidelines were reviewed by an expert work group convened by ASH.
Review included limited searches for new evidence and discussion of the search results …

Acute pulmonary embolism: a concise review of diagnosis and management

M Hepburn‐Brown, J Darvall… - Internal medicine …, 2019 - Wiley Online Library
An acute pulmonary embolism (aPE) is characterised by occlusion of one or more
pulmonary arteries. Physiological disturbance may be minimal, but often cardiac output …

Global guidelines trends and controversies in lower limb venous and lymphatic disease: Narrative literature revision and experts' opinions following the vWINter …

S Gianesini, A Obi, S Onida, D Baccellieri… - …, 2019 - journals.sagepub.com
Guidelines are fundamental in addressing everyday clinical indications and in reporting the
current evidence-based data of related scientific investigations. At the same time, a spatial …

[HTML][HTML] Deep vein thrombosis

SM Waheed, P Kudaravalli, DT Hotwagner - 2018 - europepmc.org
Deep Vein Thrombosis - Abstract - Europe PMC Sign in | Create an account https://orcid.org
Europe PMC Menu About Tools Developers Help Contact us Helpdesk Feedback Twitter Blog …

[HTML][HTML] Rationale and design of BROKEN-SWEDEHEART: a registry-based, randomized, parallel, open-label multicenter trial to test pharmacological treatments for …

E Omerovic, S James, D Erlinge, H Hagström… - American Heart …, 2023 - Elsevier
Background Takotsubo syndrome (TS) is a life-threatening acute heart failure syndrome
without any evidence-based treatment options. No treatment for TS has been examined in a …

[HTML][HTML] Can thrombus age guide thrombolytic therapy?

C Czaplicki, H Albadawi, S Partovi… - Cardiovascular …, 2017 - ncbi.nlm.nih.gov
Venous thrombosis (VT) is a common yet complex clinical condition that has shown minimal
alteration in clinical management for decades. It is well known that thrombus evolves …

Association of type of oral anticoagulant dispensed with adverse clinical outcomes in patients extending anticoagulation therapy beyond 90 days after hospitalization …

A Pawar, JJ Gagne, C Gopalakrishnan, G Iyer… - Jama, 2022 - jamanetwork.com
Importance Guidelines for managing venous thromboembolism (VTE) recommend at least
90 days of therapy with oral anticoagulants. Limited evidence exists about the optimal drug …

Impact of the COVID‐19 pandemic on therapeutic choices in thrombosis‐hemostasis

C Hermans, C Lambert - Journal of Thrombosis and Haemostasis, 2020 - jthjournal.org
Major therapeutic developments have been achieved in the field of thrombotic and
hemorrhagic diseases over the last decade. These include the development and validation …

The neutrophil secretome as a crucial link between inflammation and thrombosis

MA Blanch-Ruiz, R Ortega-Luna… - International Journal of …, 2021 - mdpi.com
Cardiovascular diseases are a leading cause of death. Blood–cell interactions and
endothelial dysfunction are fundamental in thrombus formation, and so further knowledge of …